PDS Biotechnology Corp.
(NASDAQ : PDSB)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc. -0.54%36.620.9%$932.21m
JNJJohnson & Johnson 1.37%149.190.7%$929.28m
MRKMerck & Co., Inc. 0.20%85.810.7%$708.99m
ABBVAbbVie, Inc. 0.51%90.091.9%$663.11m
BMYBristol-Myers Squibb Co. -0.24%59.261.0%$570.06m
LLYEli Lilly & Co. 1.00%153.991.1%$551.38m
AZNAstraZeneca Plc 0.95%56.471.2%$253.14m
NVSNovartis AG -0.07%90.910.2%$166.45m
PRNBPrincipia Biopharma, Inc. 0.22%100.270.0%$118.06m
GSKGlaxoSmithKline Plc -0.53%39.260.2%$100.52m
CVACCureVac NV -1.53%52.090.0%$72.77m
RGENRepligen Corp. 0.19%145.997.1%$54.44m
NVONovo Nordisk A/S -0.19%69.440.1%$54.24m
SNYSanofi 0.71%52.440.2%$49.05m
OPKOPKO Health, Inc. 1.28%3.1711.2%$47.24m

Company Profile

PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products PDS0101, is an off the shelf immunotherapeutic that is administered by subcutaneous injection. The company was founded by Frank K. Bedu-Addo on March 15, 2019 and is headquartered in Princeton, NJ.